The WHO currently recommends ferritin as the best biomarker for measuring the iron status of populations; however, the recommendation is currently being reviewed and updated. Thus, the “WHO guideline development group – ferritin” was established. This guideline development group will convene from June 15-17, 2016, in Geneva, Switzerland. The main objectives of this meeting include finalizing guidance on the use of ferritin concentrations to assess iron status in populations, discussing both strengths and challenges of the recommendations, and determining implications for further research.
June 15-17, 2016